Prime Video released the first trailer for Vought Rising on May 22, 2026, moments after The Boys concluded its fifth and final season — dropping the franchise's next chapter at the exact moment millions of viewers were most primed to receive it. The 1950s-set prequel stars Jensen Ackles as the young soldier who will become Soldier Boy and Aya Cash returning as Clara Vought, the character later revealed in The Boys as the Nazi-origin supe known as Stormfront. Showrunner Paul Grellong describes the series as a "twisted murder mystery" about the origins of Vought International, and the trailer confirms it: injection sequences, a psychiatric facility used as an experimental black site, Cold War-era military branding, and an early version of Compound V being administered to servicemen who have no idea what it will do to them.
What makes Vought Rising worth examining beyond its franchise positioning is how much of its science it gets right — and how precisely it maps its fictional atrocities onto real ones.
Soldier Boy's Origin Parallels Real Operation Paperclip History
The trailer shows American servicemen receiving injections at a facility called Fort Harmony while a voiceover declares that "God blessed us with these extraordinary heroes" — branding a pharmacological experiment as divine providence. In the franchise's established lore, Vought's founder defected to the United States after the war with a gene-altering compound developed through concentration camp experiments, then began human trials on US military subjects. This mirrors Operation Paperclip, in which officials within the Joint Intelligence Objectives Agency brought more than 1,600 German scientists to the United States between 1945 and 1959, and bypassed President Truman's directive against recruiting Nazi members by whitewashing incriminating evidence of war crimes from their records.
The show's writers did not invent this mechanism. They found it in the historical record and dramatized it with a specific fictional endpoint: superhuman soldiers instead of rocket programs. The ethical structure is identical.
Sage Grove Center Maps Directly Onto MKULTRA
The trailer shows scientists experimenting on subjects inside Sage Grove Center, the psychiatric hospital seen earlier in The Boys as a Vought black site for involuntary enhancement. In April 1953, CIA Director Allen Dulles approved what became Project MKULTRA, a program that ran experiments across hospitals and mental institutions on subjects who had not consented. The program's chief scientist, Sidney Gottlieb, later admitted under Senate questioning that "a lot of these things were done in hospitals and mental institutions. And when you say hospitalization, the people were already hospitalized." A Church Committee investigation in 1975 made the program public knowledge.
Vought Rising is dramatizing what MKULTRA would have looked like if the objective had been pharmacological superhuman enhancement instead of mind control. The institutional apparatus — military funding, psychiatric cover, non-consensual subjects — is drawn from real history.
What Compound V Gets Right About Gene Therapy
The franchise's most scientifically accurate detail is one that is easy to miss: in The Boys universe, Compound V works better on infants than adults. This is not hand-waving — it is a real property of gene therapy vectors.
Adeno-associated virus (AAV) delivery, the leading vector for real-world gene therapy, is significantly more effective in neonates and young subjects than in adults. Research has established that adult immune systems mount stronger responses against viral capsid proteins, degrading the therapeutic vector before it can do its work. Infant administration bypasses this because the immune system has not yet been primed against the capsid antigens. The show's worldbuilding observation follows directly: a serum delivered via viral vector would work better in babies because their immune defenses are not yet calibrated to destroy it.
The stochastic nature of V-One — same batch, radically different powers in different subjects — is also grounded in real biology. Even identical gene-editing interventions produce variable phenotypes because chromatin context varies across individuals: a gene insertion near an active promoter produces a different outcome than the same insertion in a transcriptionally silent region. The franchise's "thousands of deaths" in V-One's early trials maps onto documented gene therapy history. In 1999, Jesse Gelsinger became the first person publicly identified as dying in a gene therapy clinical trial, suffering a massive immune reaction to an adenoviral vector that caused multi-organ failure within four days. Gelsinger was 18 and relatively healthy before the trial. His death halted the gene therapy field for nearly a decade.
Where V-One Parts Ways With Biology
Vought Rising's central science fiction — V-One's ability to confer biological immortality — is the one place where the franchise's lore departs most dramatically from what is possible.
Telomerase, the enzyme that extends chromosomal telomeres and is central to cellular aging, is constitutively activated in 85 to 90 percent of all human tumors. That figure is not incidental: telomerase reactivation is the primary mechanism by which cancer cells achieve replicative immortality. A gene therapy designed to halt aging by reactivating telomerase would, without simultaneous suppression of oncogenesis, produce malignancy at high probability rather than Soldier Boy. Halting aging in a living adult would require not only telomerase reactivation but also suppression of oxidative protein damage, maintenance of mitochondrial function, prevention of senescent cell accumulation, and inhibition of every downstream pathway that drives age-related deterioration. No single compound can achieve this. No combination of current interventions can achieve it simultaneously.
Vought Rising handles this limitation with unusual intellectual honesty. Within the franchise's lore, V-One's immortality effect is an irreproducible 1950s anomaly — Vought itself could not replicate it — which is the most defensible move a fictional universe can make when it asks viewers to accept something real biology cannot yet support.
Jensen Ackles, Aya Cash, and 2027 Premiere
The trailer's cast extends beyond its two leads. Mason Dye returns as Bombsight, a supe who appeared in The Boys Season 5. Elizabeth Posey plays Private Angel, a nurse-inspired supe; Will Hochman plays Torpedo. KiKi Layne, Jorden Myrie, Nicolo Pasetti, Ricky Staffieri, and Brian J. Smith round out the ensemble. Both Ackles and Cash serve as producers in addition to starring. The series is produced by Sony Pictures Television and Amazon MGM Studios in association with Kripke Enterprises, Point Grey Pictures, and Original Film. Eric Kripke, Seth Rogen, and Evan Goldberg are among the executive producers. Vought Rising is scheduled to premiere on Prime Video in 2027; no specific air date has been announced.
The show arrives at a structurally significant moment. The Boys spent five seasons building toward the argument that the social machinery producing superheroes — corporate capture of biology, state-sponsored violence rebranded as heroism, science absorbed from its perpetrators and laundered through PR — is indistinguishable from the machinery that produces atrocity. Vought Rising takes that argument back to the moment the machinery was assembled: 1950s New York, a Cold War government with a blank check and a scientist with a formula, and soldiers who wanted to fight for the flag and had no idea what that would cost them.
ⓒ 2026 TECHTIMES.com All rights reserved. Do not reproduce without permission.
